ACHV
Achieve Life Sciences Inc
7.40$
+3.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | |
| -3.0% | -3.2% | -15.7% | -5.0% | 903.5% | 59.7% | 35,840.0% | 30,600.0% | 4.0% | 296.7% | 35.6% | 20.6% | 38.8% | 79.1% | 135.7% | 392.1% | 198.8% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 103.0% | 103.2% | 115.7% | 105.0% | -803.5% | 40.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | |
| 67.5% | 61.4% | 205.9% | 46.3% | 797.9% | 59.7% | 35,827.0% | 30,613.9% | 4.0% | 296.7% | 183.6% | 134.9% | 38.8% | 94.6% | 135.7% | 392.2% | 198.8% | 185.1% | 170.5% | 138.3% | 292.1% | – | – | – | – | – | – | – | – | – | |
| 23.0% | 38.1% | 128.4% | 47.8% | 967.2% | 37.8% | 12,969,368.0% | 12,038,660.0% | 2,215.2% | 67,479.1% | 33,835.0% | 40,827.7% | 16.4% | 15.5% | 42.9% | 113.4% | 38.8% | 33.1% | 39.2% | 65.0% | 176.5% | – | – | – | – | – | – | – | – | – | |
| 93.4% | 102.6% | 349.0% | 105.0% | 1,871.0% | 97.5% | 48,796.4% | 42,652.6% | 6.3% | 364.2% | 217.4% | 175.7% | 55.2% | 110.1% | 178.6% | 505.5% | 237.6% | 218.2% | 209.7% | 203.3% | 468.6% | – | – | – | – | – | – | – | – | – | |
| 9.6% | 0.5% | -233.3% | 7.4% | -1,771.0% | 2.5% | -48,696.4% | -42,552.6% | -6.3% | -264.2% | -117.4% | -75.7% | -31.1% | -9.7% | -108.3% | -405.5% | -129.3% | -118.2% | -108.7% | -103.3% | -418.6% | – | – | – | – | – | – | – | – | – | |
| 1.2% | 5.1% | 3.9% | 3.9% | 8.3% | 0.2% | 126.7% | 168.5% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 7.5% | 0.0% | 0.0% | 0.0% | 2.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 13.3% | 5.8% | -219.0% | 3.6% | -569.1% | 8.5% | -46,949.1% | -41,868.4% | -6.2% | -264.2% | -117.9% | -76.3% | -53.1% | -9.7% | -114.5% | -267.0% | -105.0% | -106.6% | -96.8% | -92.5% | -397.6% | – | – | – | – | – | – | – | – | – | |
| 3.0% | 0.5% | -14.3% | 3.9% | -43.3% | 2.3% | -405.9% | -684.2% | -0.1% | -8.6% | -12.2% | -10.8% | -10.2% | 11.8% | -22.0% | -138.5% | -32.6% | -11.6% | -12.9% | -10.7% | -21.0% | – | – | – | – | – | – | – | – | – | |
| 10.2% | 5.3% | -219.6% | 3.3% | -525.8% | 6.2% | -46,543.2% | -41,868.4% | -6.2% | -255.6% | -105.2% | -64.9% | -20.9% | 21.4% | -92.4% | -267.0% | -105.0% | -106.6% | -96.8% | -92.5% | -397.6% | – | – | – | – | – | – | – | – | – | |
| 12.7% | 3.7% | -217.3% | 4.9% | -2,724.0% | 5.4% | -46,373.9% | -41,030.9% | -5.9% | -248.3% | -102.4% | -61.6% | -52.7% | 5.6% | -114.1% | -404.1% | -104.5% | -105.8% | -95.9% | -101.9% | -393.9% | – | – | – | – | – | – | – | – | – |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.